Jan‐Willem C. Alffenaar
The University of Sydney(AU)University Medical Center Groningen(NL)Radboud University Nijmegen(NL)University of Groningen(NL)Taronga Conservation Society Australia(AU)Radboud University Medical Center(NL)Westmead Hospital(AU)UNSW Sydney(AU)Infectious Diseases Institute(UG)Westmead Institute(AU)Sydney Local Health District(AU)Westmead Institute for Medical Research(AU)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Antibiotics Pharmacokinetics and Efficacy, Antifungal resistance and susceptibility, Pneumocystis jirovecii pneumonia detection and treatment, Pneumonia and Respiratory Infections
Most-Cited Works
- → Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#(2020)980 cited
- → Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis(2018)625 cited
- → Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents(2009)446 cited
- → Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases(2020)401 cited
- → Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot–Based Methods for Therapeutic Drug Monitoring(2019)303 cited
- → Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement(2014)